Frontier Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-6,591
| Closed | -$1.52M | – | 270 |
|
|
2023
Q2 | $1.52M | Buy |
+6,591
| New | +$1.52M | 0.01% | 252 |
|
|
2020
Q4 | – | Sell |
-27,299
| Closed | -$3.24M | – | 289 |
|
|
2020
Q3 | $3.24M | Sell |
27,299
-44,615
| -62% | -$5.3M | 0.03% | 276 |
|
|
2020
Q2 | $8.14M | Sell |
71,914
-20,998
| -23% | -$2.38M | 0.07% | 234 |
|
|
2020
Q1 | $6.2M | Buy |
92,912
+38,712
| +71% | +$2.58M | 0.07% | 224 |
|
|
2019
Q4 | $4.94M | Buy |
54,200
+32,718
| +152% | +$2.98M | 0.04% | 252 |
|
|
2019
Q3 | $1.85M | Sell |
21,482
-5,993
| -22% | -$517K | 0.01% | 273 |
|
|
2019
Q2 | $2.88M | Sell |
27,475
-60,228
| -69% | -$6.31M | 0.02% | 276 |
|
|
2019
Q1 | $11M | Buy |
87,703
+3,835
| +5% | +$480K | 0.08% | 230 |
|
|
2018
Q4 | $9.45M | Buy |
+83,868
| New | +$9.45M | 0.08% | 236 |
|